Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions

Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology
F C OddsP F Troke

Abstract

Low, reproducible minimal inhibitory concentrations against Candida species, with sharp, precise end points in complex media were achieved for imidazoles (clotrimazole, econazole, miconazole, tioconazole and ketoconazole) and triazoles (fluconazole, itraconazole, vibunazole, ICI 153066) by including in the test medium antibacterial antibiotics that bind to the 80S eukaryotic ribosome and inhibit protein synthesis, i.e. blasticidin, cycloheximide, doxycycline, neomycin and gentamicin. The presence of these antibiotics reduced MICs, on average, by 50- to 250-fold. Other protein synthesis inhibitors (rifampicin, erythromycin, lincomycin, clindamycin, chloramphenicol and fusidic acid) were not effective, and the antibiotics did not affect MICs for Aspergillus species. The low azole MICs were in close agreement with MICs obtained in a defined, tissue culture-based medium lacking added antibiotics.

References

Sep 1, 1978·Antimicrobial Agents and Chemotherapy·M A LewM J Levin
Jul 1, 1972·Antimicrobial Agents and Chemotherapy·S N SchwartzD Schlessinger
Jan 1, 1971·Annual Review of Microbiology·S Pestka
Dec 1, 1982·The Journal of Antimicrobial Chemotherapy·W H Beggs

❮ Previous
Next ❯

Citations

Apr 1, 1992·Neonatal Network : NN·B Noerr
Apr 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Espinel-Ingroff, S Shadomy
Jan 1, 1993·Antimicrobial Agents and Chemotherapy·R A FromtlingG D Roberts
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·O MarchettiD Sanglard
Jul 1, 1991·The Journal of Infection·R J Coker, J R Harris
Jul 17, 2008·Expert Opinion on Pharmacotherapy·Pascale QuatresoozGérald E Piérard
May 10, 2012·Expert Opinion on Pharmacotherapy·Gérald E PiérardClaudine Piérard-Franchimont
Jan 1, 1988·Annals of the New York Academy of Sciences·P F TrokeM H Tarbit
Sep 1, 1990·DICP : the Annals of Pharmacotherapy·M T PaskoA D Van Slooten
May 16, 2020·Infectious Diseases in Obstetrics and Gynecology·A F D Di StefanoA Comandini
Jul 8, 2017·BioMed Research International·Wisam AlhamadiHussam W Al-Humadi
Oct 1, 1993·Clinical Microbiology Reviews·J H RexJ N Galgiani
Sep 1, 1988·Journal of Clinical Microbiology·M A GordonP G Passero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.